Tat-Smad7 fusion protein (Allander Biotechnologies)

N/A

Report date: 2025/03/20 09:14:54

Base Information

Drug NameTat-Smad7 fusion protein (Allander Biotechnologies)
Drug Alias NameTat-Smad7 fusion protein (Taiga Biotechnologies)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products modulatorsMothers against decapentaplegic homolog 7 modulators
TargetsHuman Immunodeficiency Virus tat Gene ProductsMothers against decapentaplegic homolog 7
Therapy Area/IndicationsWounds and InjuriesStomatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaiga Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesAllander Biotechnologies
Inactive CompaniesTaiga Biotechnologies Inc
Active IndicationsWounds and Injuries
Inactive IndicationsStomatitis

Other Information

ATC CodeN/A
Related LinksN/A